Biological Bank for Atrial Fibrillation and Stroke

Launched by HOSPICES CIVILS DE LYON · Jul 26, 2018

Keywords

ClinConnect Summary

This clinical trial, called the Biological Bank for Atrial Fibrillation and Stroke, is investigating the genetic factors that may contribute to atrial fibrillation (AF) and strokes. Atrial fibrillation is a common heart rhythm disorder that can lead to strokes, especially in older adults. Researchers believe that understanding the genetic links between AF and stroke could help identify new treatments. They are collecting biological samples to study these connections further.

If you or a loved one have a history of atrial fibrillation or stroke, you might be eligible to participate in this study. The trial is open to individuals aged 65 and older, as well as some younger participants with specific conditions. Participants can expect to provide medical information and biological samples, which will help researchers learn more about the causes of AF and stroke. It's important to know that all participants must agree to take part in the study by signing a consent form. This research could lead to better treatments for those affected by these conditions in the future.

Gender

ALL

Eligibility criteria

• • Group 1a
• * Inclusion Criteria :
• • - AF history
• * Exclusion Criteria :
• • No AF history
• • patient who didn't signed consent
• • Group 1b
• * Inclusion Criteria :
• • AF history
• • Scheduled electrophysiological exploration or AF ablation
• * Exclusion Criteria :
• • No AF history
• • pregnant women
• • patient who didn't signed consent
• • Group 1c
• * Inclusion Criteria :
• • AF/AT history
• • Stroke history
• * Exclusion Criteria :
• • No Stroke history
• • patient who didn't signed consent
• • Group 2
• * Inclusion Criteria :
• • patient over 80
• • ECG: sinusal rhythm
• • TTE : no left atrial dilatation
• * Exclusion Criteria :
• • atrial fibrillation history
• • TTE : Left atria \>25cm², \> 34m/m2), FEVG \< 50%
• • ECG : QRS \> 90 ms
• • cardiac pathologies (excepted hypertension and valvulopathies)
• • History of stroke and transient ischemic attack
• • patient who didn't signed consent
• • Group 3
• * Inclusion Criteria :
• • cryptogenic stroke or transient ischemic attack history before 50 yo
• • No AF history
• * Exclusion Criteria :
• • AF history
• • stroke or transient ischemic attack over 50 yo
• • patient who didn't signed consent